Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
Leonie J M Mekenkamp, Jolien Tol, Jeroen R Dijkstra, Inge de Krijger, M Elisa Vink-Börger, Shannon van Vliet, Steven Teerenstra, Eveline Kamping, Eugène Verwiel, Miriam Koopman, Gerrit A Meijer, J Han Jm van Krieken, Roland Kuiper, Cornelis J A Punt, Iris D Nagtegaal
Research output: Contribution to journal › Article › peer-review
61Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients'. Together they form a unique fingerprint.